Jupiter Neurosciences is a biotechnology company that focuses on developing a treatment for Alzheimer and rare neurological disorders.
Jupiter Neurosciences has raised $3.8M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Jupiter Neurosciences's investors include PharmAla Biotech, Yorkville Advisors, Centrecourt Asset Management.
Jupiter Neurosciences is headquartered in Palm Beach Gardens, United States.
Jupiter Neurosciences is a biotechnology company that focuses on developing a treatment for Alzheimer and rare neurological disorders.
Jupiter Neurosciences is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Jupiter Neurosciences — Funding & Investors." VCBacked, May 20, 2026, https://www.vcbacked.co/company/jupiter-neurosciences. Accessed August 13, 2026.
VCBacked. (2026). Jupiter Neurosciences — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/jupiter-neurosciences
{{cite web |title=Jupiter Neurosciences — Funding & Investors |url=https://www.vcbacked.co/company/jupiter-neurosciences |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated